Dopamine receptors are targets for drugs with antipsychotic potency, and they are also the primary target in the treatment of Parkinson’s disease. Molecular cloning has identified five genes that code for dopamine receptors. These receptors belong in two functionally distinct classes of G-protein-coupled receptors, known as the D1 class of receptors (D1 and D5) and the D2 class of receptors (D2, D3, and D4). The diversity of dopamine receptor subtypes that belong to the same functional class, their high degree of structural similarity, and the lack of antagonists with selectivity for each of the individual subtypes have challenged studies on the function of the individual receptor subtypes. This review focuses on the recent progress made with studies on the expression and function of D1, D2, and D3 receptors. It summarizes results of studies that suggest that these receptor proteins are expressed in monomeric and oligomeric forms and reviews results of a growing number of gene-targeting studies that begin to illustrate major differences in the phenotypes of D1-, D2-, and D3-mutant mice.
Shafer RA, Levant B.The D3 dopamine receptor in cellular and organismal function. Psychopharmacology1998;135:1-16.
4.
Sibley DR. New insight into dopaminergic receptor function using antisense and genetically altered animals. Ann Rev Pharmacol Toxicol1999;39:313-341.
5.
Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol1990;213:899-929.
O’Dowd BF. Structure of dopamine receptors. J Neurochem1993;60:804-816.
8.
O’Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, Bovier RJ. Palmytoylation of the human β2 adrenergic receptor: mutation of CYS341 in the carboxy tail leads to an uncoupled, non-palmitoylated form of the receptor. J Biol Chem1989;264:7564-7569.
9.
Ovchinnikov V, Abdulaev N, Bogachuk A.Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated. FEBS Lett1988;230:1-5.
10.
Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. Chimeric α -,β -adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science1988;240:1310-1316.
11.
Maggio R, Vogel Z, Wess J.Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular “cross-talk” between G-protein-coupled receptors. Proc Natl Acad Sci U S A1993;90:3103-3107.
12.
Wreggett KA, Wells W.Cooperativity manifest in the binding properties of purified cardia muscarinic receptors. J Biol Chem1995;270:22488-22499.
13.
Hebert TE, Moffett S, Morello J-P, Loisel TP, Bichet DG, Barret C, et al.A peptide derived from a β -adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem1996;271:16384-16392.
14.
Ng GYK, Mouillac B, George SR, Caron M, Dennis M, Bovier M, et al.Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol1994;267:7-19.
15.
Ng GYK, O’Dowd BF, Caron M, Dennis M, Brann MR, George SR. Phosphorylation and palmitoylation of the human D2l dopamine receptor in Sf9 cells. J Neurochem1994;63:1589-1595.
16.
Zawarynski P, Tallerico T, Seeman P, Lee SP, O’Dowd BF, George SR. Dopamine D2 receptor dimers in human and rat brain. FEBS Lett1998;441:383-386.
17.
Nimchinsky EA, Hof PR, Janssen WGM, Morrison JH, Schmauss C.Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem1997;272:29229-29237.
18.
Schmauss C.Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci1996;16:7902-7909.
19.
Liu K, Bergson C, Levenson R, Schmauss C.On the origin of mRNA encoding the truncated dopamine D -type receptor D and detection of D -like immunoreactivity in human brain. J Biol Chem1994;269:29220-29226.
20.
Wang Z-Z, Hardy SF, Hall ZW. Assembly of the nicotinic acetylcholine receptor. J Biol Chem1996;271:27575-27584.
21.
Jung M-Y, Skryabin BV, Arai M, Abbondanzo S, Fu D, Brosius J, et al.Potentiation of the D2-mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience1999;91:911-924.
22.
George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GYK, et al.A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem1998;273:30244-30248.
23.
Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park B-H, et al.A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci U S A1996;93:1945-1949.
24.
Weiss S.Fluorescence spectroscopy of single biomolecules. Science1999;283:1676-1683.
25.
Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, et al.Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell1994;79:729-742.
26.
Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, et al.Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA1994;91:12564-12568.
27.
Moratalla R, Xu M, Tonegawa S, Graybiel AM. Cellular responses to psychostimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A1996;93:14928-14933.
28.
Xu M, Hu X-T, Cooper DC, Moratalla R, Graybiel AM, White FJ, et al.Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell1994;79:945-955.
29.
Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP, et al.Behavioral assessment of mice lacking D dopamine receptors. Neuroscience1998;86:135-146.
30.
Miner L, Drago J, Chamberlain PM, Donovan D, Uhl GR. Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport1995;6:2314-2316.
31.
Cromwell HC, Berridge KC, Drago J, Levine MS. Action sequencing is impaired in D A-deficient mutant mice. Eur J Neurosci1998;10:2426-2432.
32.
Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, et al.Behavioral phenotypes of inbred strains: implications and recommendations for molecular studies. Neuropharmacology1997;132:107-124.
33.
Drago J, Gerfen CR, Westphal H, Steiner H.D1-dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience1996;74:813-823.
34.
Baik J-H, Picetti R, Dalardi A, Thirlet G, Dierich A, Depaulis A, et al.Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature1995;377:424-428.
35.
Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, et al.Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron1997;19:103-113.
36.
Jung M-Y, Hof PR, Schmauss C.Expression of calbindin-D28K immunoreactivity in the dorsal striatum of mice lacking dopamine D2, D3, and D2/D3 receptors. Soc Neurosci Abstr1999;25:151-158.
37.
Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang, et al.Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci1998;18:3470-3479.
38.
Schöneberg T, Liu J, Wess J.Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptors. J Biol Chem1995;270:18000-18006.
39.
Saiardi A, Bozzi Y, Baik J-H, Borelli E.Antiproliferative role of dopamine: loss of D receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron1997;19:115-126.
40.
Mercuri NB, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernadi G, et al.Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience1997;79:323-327.
41.
L’hirondel ML, Cheramy A, Godeheu G, Artaud F, Saiardi A, Borreli E, et al.Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res1998;792:253-262.
42.
Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borreli E.Absence of opiate rewarding effects in mice lacking dopamine D2 and D3 receptors. Nature1997;388:586-589.
43.
Phillips T, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, et al.Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nature Neurosci1998;1:610-615.
44.
El-Ghundi M, George SR, Drago J, Fletcher PJ, Fan T, Nguyen T, et al.Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol1998;353:149-158.
45.
Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu X-T, et al.Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron1997;19:837-848.
46.
Koeltzow TE, Xu M, Cooper DC, Hu X-T, Tonegawa S, Wolf ME, et al.Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci1998;18:2231-2238.
